Carcinoma neuroendocrino de esófago: reporte de caso

Yomaira Mendoza-Hayashida; Harold Benites-Goñi; Alonso Soto

Carcinoma neuroendocrino de esófago: reporte de caso

Translated title of the contribution: Neoendocrine carcinoma of the esophagus: report of a case

Yomaira Mendoza-Hayashida
, Harold Benites-Goñi
, Alonso Soto

Faculty of Health Sciences

Universidad Peruana de Ciencias Aplicadas
Hospital Nacional Edgardo Rebagliati Martins (HNERM)

Research output: Contribution to journal › Article › peer-review

Abstract

Neuroendocrine carcinoma of esophagus represents less than 2% of cases of cancer of the esophagus. This presentation is extremely unusual, as this type of carcinoma typically presents with greater frequency in bronchopulmonary regions. The symptoms are usually associated with esophageal obstruction and include odynophagia, dysphagia and weight loss and are not usually associated with Carcinoid syndrome. The diagnosis requires one or more of the following positive immunohistochemical markers: Chromogranin A, synaptophysin or CD56 positive, as well as the presence of EMA and PANCK positive. We report the case of a male patient with diagnosis of neuroendocrine tumor of esophagus.

Translated title of the contribution	Neoendocrine carcinoma of the esophagus: report of a case
Original language	Spanish
Pages (from-to)	293-296
Number of pages	4
Journal	Revista de gastroenterología del Perú : órgano oficial de la Sociedad de Gastroenterología del Perú
Volume	38
Issue number	3
State	Published - 1 Jul 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@article{335d6487193f4d9abf19c6d441f7736e,

title = "Carcinoma neuroendocrino de es{\'o}fago: reporte de caso",

abstract = "Neuroendocrine carcinoma of esophagus represents less than 2\% of cases of cancer of the esophagus. This presentation is extremely unusual, as this type of carcinoma typically presents with greater frequency in bronchopulmonary regions. The symptoms are usually associated with esophageal obstruction and include odynophagia, dysphagia and weight loss and are not usually associated with Carcinoid syndrome. The diagnosis requires one or more of the following positive immunohistochemical markers: Chromogranin A, synaptophysin or CD56 positive, as well as the presence of EMA and PANCK positive. We report the case of a male patient with diagnosis of neuroendocrine tumor of esophagus.",

author = "Yomaira Mendoza-Hayashida and Harold Benites-Go{\~n}i and Alonso Soto",

year = "2018",

month = jul,

day = "1",

language = "Espa{\~n}ol",

volume = "38",

pages = "293--296",

journal = "Revista de gastroenterolog{\'i}a del Per{\'u} : {\'o}rgano oficial de la Sociedad de Gastroenterolog{\'i}a del Per{\'u}",

issn = "1022-5129",

publisher = "Sociedad De Gastroenterologia Del Peru",

number = "3",

}

TY - JOUR

T1 - Carcinoma neuroendocrino de esófago

T2 - reporte de caso

AU - Mendoza-Hayashida, Yomaira

AU - Benites-Goñi, Harold

AU - Soto, Alonso

PY - 2018/7/1

Y1 - 2018/7/1

N2 - Neuroendocrine carcinoma of esophagus represents less than 2% of cases of cancer of the esophagus. This presentation is extremely unusual, as this type of carcinoma typically presents with greater frequency in bronchopulmonary regions. The symptoms are usually associated with esophageal obstruction and include odynophagia, dysphagia and weight loss and are not usually associated with Carcinoid syndrome. The diagnosis requires one or more of the following positive immunohistochemical markers: Chromogranin A, synaptophysin or CD56 positive, as well as the presence of EMA and PANCK positive. We report the case of a male patient with diagnosis of neuroendocrine tumor of esophagus.

AB - Neuroendocrine carcinoma of esophagus represents less than 2% of cases of cancer of the esophagus. This presentation is extremely unusual, as this type of carcinoma typically presents with greater frequency in bronchopulmonary regions. The symptoms are usually associated with esophageal obstruction and include odynophagia, dysphagia and weight loss and are not usually associated with Carcinoid syndrome. The diagnosis requires one or more of the following positive immunohistochemical markers: Chromogranin A, synaptophysin or CD56 positive, as well as the presence of EMA and PANCK positive. We report the case of a male patient with diagnosis of neuroendocrine tumor of esophagus.

UR - https://www.scopus.com/pages/publications/85058607107

M3 - Artículo

C2 - 30540735

AN - SCOPUS:85058607107

SN - 1022-5129

VL - 38

SP - 293

EP - 296

JO - Revista de gastroenterología del Perú : órgano oficial de la Sociedad de Gastroenterología del Perú

JF - Revista de gastroenterología del Perú : órgano oficial de la Sociedad de Gastroenterología del Perú

IS - 3

ER -

Carcinoma neuroendocrino de esófago: reporte de caso

Abstract

UN SDGs

Other files and links

Fingerprint

Cite this